secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0001493152-24-015404
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics receives NYSE American noncompliance notice; equity $3.2M below $4M/$6M thresholds
--------------------------------------------------------------------------------

- NYSE American notified Oragenics it fails continued listing standards due to stockholders' equity of $3.2M as of Dec 31, 2023.
- Company must submit a compliance plan by May 18, 2024 to address Sections 1003(a)(ii) and 1003(a)(iii) deficiencies.
- Company has until October 18, 2025 to regain compliance; stock trades as OGEN.BC during this period.
- If plan is not accepted or compliance not achieved, Oragenics faces potential delisting from NYSE American.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224015404/0001493152-24-015404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224015404/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer